| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e357880cae722e6181703e20153c16ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
| filingDate |
2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6883c6342b471615145d11db603275d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e0dac712b223607e68200bfc05976b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c736a351cbba42aa48dcbf27fea9f95d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e905b22bb5202ec83f6a3d9d06c46834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7f0501b92bd89210f8bb6d1b836f5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f25a4242a0359a1ead3573d6484343c |
| publicationDate |
2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102018100967-A1 |
| titleOfInvention |
METHOD FOR DETERMINING THE EFFECTIVENESS OF VIRAL VECTORS |
| abstract |
The present disclosure relates to T cells transduced at a volumetric concentration for immunotherapy with a viral vector and to methods therefor. In another aspect, the present disclosure relates to determining the optimal lentiviral vector concentrations for transducing the T cells. The present disclosure further provides for T cell populations produced by methods described in this disclosure. |
| priorityDate |
2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |